Search clinical trials for: Inhaled iloprost

Total 1445 results

Supergene, LLC
Russian Academy of Medical Sciences

Terminated

Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial (FORRIF)

COVID-19

Russian Federation
Savara Inc.

Active, not recruiting

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA-2)

Autoimmune Pulmonary Alveolar Proteinosis

United States, Korea, Republic of, United Kingdom, Netherlands, Australia, Romania, Japan, Portugal, Canada, Greece, Spain, Italy, Poland, Belgium, France, Germany, Ireland, Turkey
IRCCS Policlinico S. Matteo
Agenzia Italiana del Farmaco

Completed

Inhaled GM-CSF Therapy of Autoimmune PAP

Autoimmune Pulmonary Alveolar Proteinosis

Italy
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Withdrawn

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

COVID-19
Jeffrey Glassberg
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 (IMPROVE2)

Sickle Cell Disease

United States
Nova Scotia Health Authority

Completed

Reduction of Anterior Shoulder Dislocation Facilitated by Inhaled Low Dose Methoxyflurane

Shoulder Dislocation

Canada
Aquilon Pharmaceuticals S.A.

Completed

Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics (BOREAS)

Asthma

Belgium
Centurion Pharma
Klinar CRO

Completed

A Clinical Study Evaluating Inhaled Aviptadil on COVID-19 (HOPE)

Covid19

Turkey
Milton S. Hershey Medical Center

Withdrawn

Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia (iGRASP)

Pneumonia | Acute Respiratory Distress Syndrome | Respiratory Virus Infection
Biozeus Biopharmaceutical S.A.
InCor Heart Institute

Terminated

Efficacy and Safety Evaluation of BZ371B in ARDS Patients

Pulmonary Disease | ARDS | ARDS, Human

Brazil
University of Miami

Completed

Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)

Total Hip Replacement | Total Knee Replacement

United States
Nemours Children's Clinic

Withdrawn

Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists

Safety of Long Acting Beta Agnoists
Washington University School of Medicine
Patient-Centered Outcomes Research Institute; University of Pennsylvania; University... and other collaborators

Active, not recruiting

THRIVE Feasibility Trial (THRIVE)

Depression | Quality of Life | Pain, Postoperative | Surgery | Anesthesia Morbidity | Surgery--Complications | Anesthesia | Nausea, Postoperative | Sleep Disorders, Circadian Rhythm | Anesthesia Awareness | Anesthesia Complication | Anesthesia Emergence Delirium

United States
Immune Biosolutions Inc

Completed

Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19

COVID-19

South Africa, Ukraine
Ellen Spurrier
Mallinckrodt

Completed

The Effects of Inhaled Nitric Oxide After Fontan Operation

Congenital Heart Defect

United States
University of Dundee

Completed

A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease

COPD
AstraZeneca
Parexel

Completed

A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
AstraZeneca
Parexel

Completed

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
University of Chicago

Active, not recruiting

Inhaled Nitric Oxide and Neuroprotection in Premature Infants (NOVA2)

Intraventricular Hemorrhage | Bronchopulmonary Dysplasia | Prematurity | Periventricular Leukomalacia

United States
Immune Biosolutions Inc

Completed

Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness

COVID-19

South Africa, Brazil
Bayer

Terminated

This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS) (SEAL)

Acute Respiratory Distress Syndrome

United Kingdom, Spain, Germany, Czechia, Austria, Italy, France
Seoul National University Hospital

Active, not recruiting

Anesthesia and Cancer Study: Renal Cell Carcinoma

Renal Cell Carcinoma

Korea, Republic of
Savara Inc.

Completed

Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (IMPALA)

Autoimmune Pulmonary Alveolar Proteinosis

United States, United Kingdom, Denmark, Switzerland, Australia, Portugal, Italy, Greece, Netherlands, Japan, Germany, France, Israel, Korea, Republic of, Russian Federation, Slovakia, Spain, Turkey
Sedana Medical

Completed

Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old (IsoCOMFORT)

Sedation

Spain, United Kingdom, Germany, France, Sweden
King Hussein Cancer Center
ACDIMA Biocenter; Sana Pharmaceutical Industry; Amman Pharmaceutical Industries...

Withdrawn

The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients

2019 Novel Coronavirus

Jordan
Promomed, LLC

Completed

Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
Spanish Breast Cancer Research Group
Bristol-Myers Squibb

Completed

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

Metastatic Breast Cancer

Spain
Association Nationale pour les Traitements A Domicile...

Completed

Evaluation of the Right Use of Inhaled Therapeutics (ARGOS)

COPD Asthma

France
Synairgen Research Ltd.

Completed

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 (SPRINTER)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
MEDA Pharma GmbH & Co. KG

Completed

Dymista Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Duke University

Completed

Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care (MADCO-PC)

Postoperative Delirium | Alzheimers Disease | Post Operative Cognitive Dysfunction

United States
AstraZeneca

Completed

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Asthma

United Kingdom
NHS Tayside
NHS Fife

Withdrawn

Steroid Withdrawal Intervention in Fife and Tayside (SWIFT)

Chronic Obstructive Pulmonary Disease

United Kingdom
Erasmus Medical Center
Chiesi Farmaceutici S.p.A.

Terminated

Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial (FORZA)

Bronchiectasis

Netherlands
Vibeke Backer

Withdrawn

The Influence of Exercise and Hydration to the Pharmacological Response to Inhaled Terbutalin and Salbutamol in Men

Healthy

Denmark
Ottawa Hospital Research Institute
University of Ottawa

Completed

Prehospital Analgesia in Adults Using Inhaled Methoxyflurane : A Feasibility Study

Trauma | Pain, Acute

Canada
University of California, San Diego
Migraine Research Foundation

Completed

Efficacy of Inhaled Cannabis for Acute Migraine Treatment

Migraine | Cannabis | CBD | THC

United States
Bellerophon

Active, not recruiting

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Pulmonary Fibrosis | Pulmonary Hypertension

United States
Bellerophon Pulse Technologies

Completed

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
Bellerophon Pulse Technologies

Completed

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) (PAH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension

United States, Canada
Boston Children's Hospital
FDA Office of Orphan Products Development

Terminated

Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis

Sickle Cell Disease

United States
Boehringer Ingelheim

Completed

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

Pulmonary Disease, Chronic Obstructive

China
Bellerophon Pulse Technologies
Worldwide Clinical Trials

Terminated

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH (INOvation-1)

Pulmonary Arterial Hypertension

United States, Australia, Canada, Israel, Netherlands, Serbia, Spain, United Kingdom, Croatia, Portugal, Germany, Austria, Belgium, Colombia, Czechia, France, Italy, Ukraine
Bellerophon Pulse Technologies

Terminated

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 (COViNOX)

COVID-19 | Coronavirus Infection | Coronavirus

United States
Bellerophon

No longer available

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

COVID-19 | Coronavirus Infection | Pneumonia, Viral
Bellerophon

Completed

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Chronic Obstructive Pulmonary Disease | Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension

Belgium
Bellerophon Pulse Technologies
Worldwide Clinical Trials

Withdrawn

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

Pulmonary Arterial Hypertension

United States, Canada
Bellerophon

Terminated

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | COPD

Belgium
Bellerophon

Available

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Pulmonary Fibrosis | Pulmonary Hypertension
Bellerophon Pulse Technologies

Active, not recruiting

Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH

Pulmonary Arterial Hypertension

United States, Canada

Search clinical trials for: Inhaled iloprost

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations